Código QR (código de barras bidimensional)

Dose reduction of docetaxel avoids the usage of pegfilgrastim in docetaxel plus ramucirumab therapy for recurrent nonsmall cell lung cancer

Abstract Background Pegfilgrastim is recommended in docetaxel plus ramucirumab (DTX + RAM) therapy for recurrent nonsmall cell lung cancer (NSCLC) because of the associated frequency of febrile neutropenia (FN). However, the FN occurs less frequently when the dose of DTX is reduced because of other...

Fuld beskrivelse

Na minha lista:
Principais autores: Kosuke Hamai, Shinya Miyaka, Shinpei Tada, Suguru Fujita, Tetsu Hirakawa, Mirai Matsumura, Sayaka Ueno, Takuya Tanimoto, Nobuhisa Ishikawa
Format: Artigo
Sprog:Inglês
Udgivet: Wiley 2023-04-01
Serier:Cancer Reports
Fag:
docetaxel
febrile neutropenia
pegfilgrastim
ramucirumab
Online adgang:https://doi.org/10.1002/cnr2.1793
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker